Praxis Precision Medicines Inc (PRAX)

Praxis Precision Medicines Inc (PRAX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.1B; returns 1 day -2.3%, 1 week +4.6%, 1 year +42.1%.

Praxis Precision Medicines Inc. is a clinical-stage biopharmaceutical company focused on developing precision medicines for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's business model revolves around the discovery and clinical development of novel therapeutic candidates, rather than current product sales.

Groups PRAX belongs to

• Biotechnology
• Precision Medicine
• CNS Disorders
• Clinical Stage
• Clinical Stage Biopharma
• Neurological Disorders
• Neuroscience
• Epilepsy
• Rare Diseases
• Healthcare
• Biopharmaceutical
• Drug Discovery

PRAX financial model: income statement, cash flow and balance sheet